New FDA trial to ‘cure’ autism with cord blood

The start of an FDA approved clinical trial using umbilical cord blood stem cells to ‘cure’ autism was launched in the USA yesterday (21 August 2012).
Dr. Michael Chez, director of pediatric neurology at Sutter Neuroscience Institute in Sacramento, Calif., said he and his colleagues have been processing the trial for more than a year now, and they have high hopes it will succeed.
Chez got the idea to ‘treat’ autism with cord blood stem cells when he observed the cells radically cure a little boy who had cerebral palsy. “I can verify he definitely got better,” Dr Chez said. “All without extensive therapy.”